However, re-exacerbation of symptoms occurred during the tapering of the prednisone daily dose. Therefore, we decided to treat the patient with Omalizumab at the dosage of 300 mg every 4 weeks. (A) ...

Researchers conducted a cross-sectional study at six tertiary photobiology units in the United Kingdom between October 2019 ...

Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to omalizumab experienced ...

A decades-old asthma medication called omalizumab, which is sold as Xolair, has shown that it can successfully treat seasonal allergies in preliminary clinical trials. Administered as a single ...

Objectives: To describe allergic asthma and allergic rhinitis pathophysiology and review the pharmacologic, pharmacokinetic, pharmacodynamic, efficacy, and safety data for omalizumab. Methods ...